• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7)

Our Recombinant Human CEACAM7 protein is a high-quality and reliable tool for research involving tags and cell markers. This protein, representing the Carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7), is crucial for cellular adhesion, migration, and signal transduction. The product is expressed in E. coli, encompassing the full length of the mature CEACAM7 protein (36-242aa), and is tagged with an N-terminal 6xHis-SUMO for ease of purification and detection. With a purity greater than 90% as determined by SDS-PAGE, our Recombinant Human CEACAM7 protein is provided as a lyophilized powder, ensuring consistent and dependable performance for your tags and cell markers research. This product allows you to achieve precise and reliable results in various research areas, including cancer biology, inflammation, and immune response.

ACP02387

Our Recombinant Human CEACAM7 protein is a high-quality and reliable tool for research involving tags and cell markers. This protein, representing the Carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7), is crucial for cellular adhesion, migration, and signal transduction. The product is expressed in E. coli, encompassing the full length of the mature CEACAM7 protein (36-242aa), and is tagged with an N-terminal 6xHis-SUMO for ease of purification and detection.
With a purity greater than 90% as determined by SDS-PAGE, our Recombinant Human CEACAM7 protein is provided as a lyophilized powder, ensuring consistent and dependable performance for your tags and cell markers research. This product allows you to achieve precise and reliable results in various research areas, including cancer biology, inflammation, and immune response.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02387 Target NameCEACAM7
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range36-242aaMol Weight39.4kDa
Protein LengthFull Length of Mature ProteinPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ14002
Background Information
  • Uniprot Id

    Q14002

  • Target Species

    Human

  • Target Name

    CEACAM7

  • Target Full Name

    Cell adhesion molecule CEACAM7

  • Target Subcellular Location

    Cell membrane; Lipid-anchor, GPI-anchor. Apical cell membrane.

  • Target Protein Families

    Immunoglobulin superfamily, CEA family

  • Target Tissue Specificity

    Expressed in columnar epithelial cells of the colon (at protein level). Strongly down-regulated in colonic adenocarcinomas.

  • Target Research Area

    Tags & Cell Markers

  • Target Synonyms

    Carcinoembryonic antigen CGM 2; Carcinoembryonic antigen CGM2; Carcinoembryonic antigen gene family member 2; Carcinoembryonic antigen related cell adhesion molecule 7; Carcinoembryonic antigen-related cell adhesion molecule 7; CEA; CEACAM 7; CEACAM7; CEAM7_HUMAN; CGM 2; CGM2

  • Target Background

    This gene encodes a cell surface glycoprotein and member of the carcinoembryonic antigen (CEA) family of proteins. Expression of this gene may be downregulated in colon and rectal cancer. Additionally, lower expression levels of this gene may be predictive of rectal cancer recurrence. This gene is present in a CEA family gene cluster on chromosome 19. Alternative splicing results in multiple transcript variants.

Inquire Recombinant Human Carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification